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To improve the detection of SNVs in SCS data sets, we developed a statistical method called Monovar (Fig. 1a , Online Methods and Supplementary Software). Monovar leverages data from multiple single cells to discover SNVs with high confidence, and it mitigates the effects of uneven or low coverage. The method assumes that data from different loci are independent. For a particular locus, input data consist of an array of observed bases and corresponding base quality scores from multiple single cells. Monovar employs an efficient dynamic programming algorithm to calculate the posterior probability of the locus containing a variant, which forms the basis for SNV classification. This algorithm models the effects of FP errors specific to whole-genome amplification in calculating genotype likelihoods for homozygous genotypes. For heterozygous genotypes, effects of both allelic dropout and FP errors are accounted for. After detecting SNVs at a locus, each cell is genotyped based on the posterior probability of the genotype. After genotyping, an optional consensus-filtering step removes variants with support from only one cell. The final output is a VCF4 file in which each SNV is a different row, followed by a genotype vector with length equal to the number of single cells (Fig. 1a) .
We first evaluated performance on three simulated SCS data sets (Online Methods and Supplementary Note), which showed that Monovar achieved higher precision compared to Samtools, GATK UnifiedGenotyper and GATK HaplotypeCaller (Supplementary Table 1 ). To validate performance on real data, we analyzed 12 published single-cell exomes (mean coverage depth 65× and breadth 92.7%) generated by single-nucleus exome sequencing (SNES) from an isogenic fibroblast cell line (SKN2) 16 . Exome sequencing of a population of these cells at high coverage depth (59×) and breadth (99.76%) was used to construct a reference set of variants (Supplementary Note). We calculated precision and detection efficiency (recall) on the multisample SNV callset. The detection efficiency of an algorithm is defined as the percentage of true SNVs that are discovered in the single cells, and precision denotes the fraction of SNV calls that are true positives. Monovar achieved substantially higher precision (0.8376) than the GATK HaplotypeCaller (0.6641) and Samtools (0.5845), with some advantages in detection efficiency (Fig. 1b,c and Supplementary Table 2) . These data showed a major improvement in the reduction of specific FP classes, such as C:G>T:A transitions, which are the most prominent class of FP errors that arise in SCS experiments 16 ( Fig. 1d and Supplementary Fig. 1b) .
Monovar also achieved the highest dbSNP precision-83.02% of the SNVs detected by Monovar, 67.55% by GATK and 60.71% by Samtools were found in dbSNP (v138) (Supplementary Next-generation sequencing (NGS) technologies have vastly improved our understanding of the human genome and its variation in normal populations and in diseases such as cancer. However, most NGS data sets represent pooled mixtures of genomes derived from millions of cells and therefore mask variation within the tissue sample. Recently, single-cell sequencing (SCS) methods have emerged as powerful tools for resolving genomic variation in complex cell mixtures and for measuring genomic information in rare subpopulations 1 . SCS tools have had a major impact on diverse fields of biology, including neurobiology, microbiology, immunology and development 2 . In cancer research, SCS methods have greatly improved our understanding of intratumor heterogeneity and clonal evolution 3 .
While there have been substantial advances in single-cell DNA and RNA sequencing technologies, computational tools are severely lacking 2, 3 . Some progress has been made with computational methods for estimating DNA copy number 4, 5 and RNA expression 6, 7 in single cells, but methods for calling single-nucleotide variants (SNVs) have not yet been developed. In most studies to date [8] [9] [10] , standard NGS variant callers such as GATK 11 , Samtools 12 , SOAPsnp 13 , SNVMix2 (ref. 14) and Varscan2 (ref. 15 ) have been applied. These variant callers, designed for bulk tissue samples, make many assumptions regarding the underlying properties of the data. This is problematic for SCS data, which, on account of extensive whole-genome amplification (WGA), have unique properties and error profiles, including nonuniform coverage depth, allelic dropout (ADO) events, false-positive (FP) errors and false-negative (FN) errors, making it difficult to call SNVs accurately 16 Fig. 3 ).
We used Monovar to detect somatic mutations and delineate the clonal substructure of three human tumor samples from, respectively, a patient with TNBC 8 , a patient with muscle-invasive bladder cancer 17 and a patient with childhood acute lymphoblastic leukemia (ALL) 18 (Fig. 2) . On single-cell exome data from 16 tumor and 20 normal cells from the TNBC patient, Monovar detected 120 synonymous and 282 nonsynonymous somatic SNVs (Supplementary Table 4 ). Hierarchical clustering and multidimensional scaling (MDS) identified three major tumor subpopulations that shared a common genetic lineage (Fig. 2a) , as evidenced by 269 shared founder mutations that arose early in tumor evolution and unique subclonal (sub) mutations in SYNE2 and PPP2R1A (sub 1), CHRM5 and NSD1 (sub 2), and TNC (sub 3). In addition to the previously reported mutations 8 , Monovar detected an additional 163 clonal somatic mutations in genes including PTCRA, TLR1, ZNF581, ABCC10, KHDRBS1 and TNFAIP3, as well as subclonal mutations in ZNF266, NCOR1, CSRP2BP and LILRB3 (sub 1), MOGS, MANEAL and TMEM161A (sub 2), and TUBB4A and CHST7 (sub 3) (Supplementary Table 5) .
On single-cell exome data from 42 tumor cells and 11 normal cells from a muscle-invasive bladder carcinoma 17 , Monovar detected 94 somatic mutations. Hierarchical clustering and MDS analysis identified three major subpopulations of tumor cells (subs 1-3) in addition to the normal cell population. Monovar also detected 54 subclonal mutations that were unique to each subpopulation, including mutations in KIAA1958, NFATC3, VAMP3, NOP56, CYP4A11, RPL3 and PARP4 (sub 1), ZNF785 and ATM (sub 2), and Table 4 ). Monovar identified 42 additional somatic mutations that were not detected in the original study 17 , including clonal cancer gene mutations in FGFR3, CNTNAP3 and ZNF708 and subclonal cancer gene mutations in PCDH19 (sub 1), ZNF785 (sub 2) and PALB2 (sub 3) (Supplementary Table 5) .
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We also applied Monovar to targeted single-cell DNA sequencing data from a pediatric patient 18 Table 5 ). Monovar identified significant mutations in OR4C3 and GPR107 (all subclones), LRFN5, PKD2L1 and ZNF781 (present in subs 2, 4 and 5), DNAH7 (sub 1), LYAR and FMNL1 (sub 2), RGS3 (subs 4 and 5), and ADAMTS13, PRSS3 and PKD2L1 (subs 2-5). Among these mutations, the clonal mutations in OR4C3 and GPR107, and the subclonal mutations in PKD2L1, ADAMTS13, PRSS3 and RGS3 were not identified in the original study 18 (Supplementary Table 5 ).
Our data show that Monovar represents an advance for SNV calling in SCS data sets compared to standard NGS variant callers. Recent innovations that enable the analysis of RNA from thousands of single cells in parallel 19, 20 will soon be extended to DNA. Monovar is capable of analyzing large-scale data sets and handling different WGA protocols, and thus it is well suited for addressing the growing need for accurate single-cell DNA variant detection. Although this study focused on cancer data, Monovar can be applied to any SCS data set 2 . As SCS methods move into the clinic, we expect that Monovar will be used in situations where the accurate detection of SNVs is critical for patient care, such as cancer diagnosis and treatment, personalized medicine and prenatal genetic diagnosis. methods Methods and any associated references are available in the online version of the paper.
Accession codes. The data from this study were previously deposited to SRA under accessions: SRP046355, SRA053195, SRA051489, SRP044380. Model assumptions. In a single-cell sample, sequence data at different sites are assumed to be completely independent. This assumption follows what is practiced by most of the state-of-theart NGS SNV callers for the sake of simplicity. Sequencing and mapping being context dependent, this assumption might not always hold for real data 21 . But this assumption should not affect our analysis, as we are interested in calling point mutations. We also assume that the data coming from different single cells are independent. At a genomic site, the mapping and sequencing errors of different reads are assumed to be independent. Since we are interested in finding SNVs, we assume that the variants are biallelic (triallelic SNVs are rare, ~0.2% 22 ).
Calculation of genotype likelihood.
In each single cell, the sequencing data at a site contain an array of bases observed on the sequenced reads and the corresponding base qualities. Considering the variants to be biallelic, we denote the reference allele as r and the alternate allele as a at a site. For homozygous reference and variant genotypes (g = 0(rr) and g = 2(aa), respectively), the likelihood calculation does not require the effect of allelic dropout (ADO). For the case pertaining to g = 1(ra) (heterozygous variant genotype), we need to account for allelic dropout. At a genomic site s, for a single cell having sequencing data d consisting of n reads, the likelihood of g = 0 and g = 2 can be calculated as For the heterozygous genotype (g = 1), the effect of allelic dropout is considered while calculating the genotype likelihood. We assume that the preferential nonamplification due to
an ADO event can affect either of the alleles with equal probability. At a particular site, ADO affects all the reads as amplification precedes sequencing. The likelihood of g = 1 can be calculated as where In equations 1 to 4, d i represents the observed base in the i th read. p β g [1] g [2] represents the probability of β being the 'intermediate allele' given the genotype g = g [1] g [2] . β is a variable that takes value from {A, T, G, C}. The term 'intermediate allele' refers to the allele that is called after amplification. In the absence of any amplification errors, β should be either g [1] or g [2] . Due to the errors introduced during preparation of the sample, β can differ from both g [1] and g [2] . In the context of single-cell sequencing data, β accounts for the FP errors introduced during the amplification process. β is a latent random variable and we assume that it follows a discreet four-point distribution with parameter p e (Supplementary Table 6) . p e represents a prior probability that β equals an allele different from the haplotypes of the given genotype. This type of distribution has been previously proposed 23 in the context of bulk sequencing data. P ad is the prior probability of allelic dropout.
Variant calling.
Assuming diploid single cells, m single cells contain 2m chromosomes at a site. The posterior probability of the site being an SNV, P S SNV = p(s = SNV | D) is given by the S SNV probability, that at least one among 2m chromosomes contains an allele that is different from the reference allele. We introduce a random variable l, named alternate allele count, which gives us the number of chromosomes containing alleles different from the reference allele. l can vary from 0 to 2m. To employ dynamic programming for the efficient computation of these likelihood values, we define h l,j as follows: The base cases are as follows:
P p s SNV D p l D S SNV
Likelihood of alternate allele count can be obtained from h l,j values using
This type of dynamic programming approach has previously been explored 21, 24 in the context of NGS data on a population of individuals. The prior distribution on the alternate allele count is inspired by a population genetic prior: In equation 11, θ represents population-level mutation rate, which is set to 0.001 24 . Higher prior probability was assigned to alternate allele frequency of 0 or 1 because we expect that, at the vast majority of sites, a population of single-cell genomes will have identical homozygous genotypes. This prior can help limit false positives introduced by whole-genome amplification and sequencing, which occur randomly at single-cell level. Genotyping of single cells. After a site is declared to be a variant, each single cell is genotyped. For a variant site with reference allele r and alternate allele a, the genotype of a single cell can
(10) (10)
be either of {rr, ra, aa} corresponding to v ∈{0,1,2}, indicating the number of alternate alleles. The posterior probability for the genotype of j th single cell, P g D j is given by The genotype with the highest posterior probability is assigned to the single cell. A similar genotyping approach has been used previously 25 for bulk sequencing data. The genotyping results are stored as a string, called genotype vector that contains one character corresponding to one single cell. The character corresponding to a single cell can be '0': homozygous reference, '1': heterozygous variant, '2': homozygous variant and '×': insufficient coverage depth.
Consensus filtering using multiple cells. To achieve a higher quality call set, a filtering step is introduced after genotyping. The consensus filter removes low-quality variants that have lower support. Depending on the genotype vector, the SNVs that are detected only in one single cell are removed as low quality. This step helps to remove spurious FP errors that occur at random positions in the single-cell data set. This step is optional but recommended for achieving a high-quality call set.
Computational complexity of variant and genotype calling.
The variant calling and genotyping step contributes to the major computational complexity of Monovar. For the variant discovery process for a site of the genome, s, the dynamic programming algorithm comprises most of the computation. Simulation of single-cell sequencing data set. A 1-Mbp region of chromosome 20 of the human genome (hg19) was chosen as the reference genome. Assuming n cell to be the number of single cells in the population, n cell synthetic genomes were constructed from the reference genome. The SNVs introduced in synthetic singlecell genomes are the true SNVs. 1,000 SNVs (SNV rate 0.001/bp) were introduced in the reference region and those were shared by the single cells. These 1,000 SNVs served as the gold standard set. One-third of the SNVs were present in all the cells. Other one-third SNVs were present in half of the single cells. The rest of the SNVs had frequency other than 0.5 or 1 in the population and were either shared by a number of single cells or present as singletons in different single cells. Amplification errors were introduced in the singlecell genomes. Allelic dropout rate was set to 20% 8 and false-positive error rate was set to 3.2e − 5 (ref. 16 ). Paired-end sequencing reads were generated for each single cell using program dwgsim (http:// davetang.org/wiki/tiki-index.php?page=DWGSIM). Sequencing error rate was set to 0.01% while generating the reads. dwgsim also simulated base quality scores for each sequenced nucleotide. Reads were discarded at random intervals to emulate the coverage variation in single-cell sequencing data. The coverage depth of the simulated data was 24×. Three data sets varying in the number of cells (10, 15 and 20) were generated.
Isogenic cell line data. Single-cell sequencing data from an isogenic fibroblast cell line (SKN2) was used for the validation of Monovar. SKN2 is an isogenic human fibroblast cell line that was obtained from the Cold Spring Harbor Laboratory (M. Wigler). SKN2 was cultured using Dulbecco's Modified Eagle Medium with 10% FBS, penicillin-streptomycin and L-glutamine. The data consisted of exome sequencing data from 12 single cells and bulk sequencing data (reference population) from millions of cells.
Sequencing data from human tumor samples. We applied Monovar to three different human tumor samples that were previously published: a triple-negative breast cancer (TNBC) patient 8 , a muscle-invasive bladder cancer patient 17 and a childhood acute lymphoblastic leukemia (ALL) patient 18 .
Sequence alignment and data processing. For the simulated data set, raw FASTQ files were aligned to the reference genome using BWA-MEM (v0.7.12) 26 . For the SKN2 data set, BWA-MEM (v0.7.12) 26 was used to align the raw reads (FASTQ files) to the human genome (hg19). For all three human tumor data sets, sequenced reads in FASTQ format were mapped to the human genome assembly US National Center for Biotechnology Information (NCBI) build 36 (hg18) using the Burrows-Wheeler alignment tool (BWA version 0.7.12) 26 with default parameters and sampe option to create SAM files with correct mate-pair information, and read group tag that includes sample name. Samtools (0.1.19) 12 was used to convert SAM files to compressed BAM files and sort the BAM files by chromosome coordinates. The reads with lower mapping quality (≤40) were removed from the BAM files. This removed about 5% of the total reads. For the SKN2 and TNBC data sets, the Genome Analysis Toolkit (GATK v1.4-37) 11 was used to locally realign the BAM files at intervals that have indel mismatches before PCR duplicate marking with Picard (version 1.56) (http://broadinstitute.github.io/picard/).
Comparison of algorithms for performance evaluation. For the simulated data and SKN2 data, Monovar's performance was compared against GATK 11 (v3.5) and Samtools 12 (v0.1.19), two widely used NGS SNV callers. Monovar was run with default parameter values (https://bitbucket.org/hamimzafar/monovar) on pileup data obtained from the BAM files of all single cells in the data set. For GATK, we used two variant callers, UnifiedGenotyper and HaplotypeCaller. Each of them was run with default parameters as per GATK best practices recommendation (https://www. broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gatk_ tools_walkers_genotyper_UnifiedGenotyper.php, https://www. broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gatk_ tools_walkers_haplotypecaller_HaplotypeCaller.php). For the experiments with SKN2 data, HaplotypeCaller was used in most comparisons as per GATK best practices recommendation. For Samtools, the Samtools mpileup command was used, followed by bcftools for detecting variants. Maximum read depth for calling SNV was set to 10,000. For each data set, each algorithm was run on data pooled from all single cells in the data set.
Construction of the validation set for SKN2 data. For the SKN2 data, the gold standard variant set was constructed based on the results of GATK and Monovar on the reference population sequencing data. A union of the variant sets called by GATK and Monovar consisting of 51,154 SNVs was used as the gold standard variant set. 50,374 (98.5%) SNVs in the gold standard set were called by both GATK and Monovar. The rationale for computing the union is to have a gold standard variant set that is unbiased toward any variant calling algorithm, ensuring a fair comparison. The set of variants that Samtools discovered from the reference population sample was a subset of the gold standard variant set. Downsampling experiments. DownsampleSam program of the Picard toolkit (version 1.56) (http://broadinstitute.github. io/picard/) was used to downsample the exome sequencing data from SKN2 single cells. DownsampleSam allows a user to randomly extract a certain percentage of reads from the original input BAM file. For example, the following command extracts 37.7% of the reads from the input sample, which has an average coverage depth of 53×, to generate a downsampled BAM file that has a coverage depth of 20×.
$ java -jar DownsampleSam.jar I= SKN2.bam O=SKN2.20X. bam P=0.377
